My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 98

    1.

    Stability of body weight in type 2 diabetes.

    Chaudhry ZW, Gannon MC, Nuttall FQ.

    Diabetes Care. 2006 Mar;29(3):493-7.PMID: 16505494 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial.

    Barnett AH, Burger J, Johns D, Brodows R, Kendall DM, Roberts A, Trautmann ME.

    Clin Ther. 2007 Nov;29(11):2333-48.PMID: 18158075 [PubMed - indexed for MEDLINE]Related articles

    3.

    Low insulin-like growth factor-II levels predict weight gain in normal weight subjects with type 2 diabetes.

    Heald AH, Kärvestedt L, Anderson SG, McLaughlin J, Knowles A, Wong L, Grill V, Cruickshank JK, White A, Gibson JM, Brismar K.

    Am J Med. 2006 Feb;119(2):167.e9-15.PMID: 16443426 [PubMed - indexed for MEDLINE]Related articles

    4.

    Changes in patient weight and the impact of antidiabetic therapy during the first 5 years after diagnosis of diabetes mellitus.

    de Fine Olivarius N, Andreasen AH, Siersma V, Richelsen B, Beck-Nielsen H.

    Diabetologia. 2006 Sep;49(9):2058-67. Epub 2006 Jul 14.PMID: 16841232 [PubMed - indexed for MEDLINE]Related articles

    5.

    Effects of exenatide versus insulin analogues on weight change in subjects with type 2 diabetes: a pooled post-hoc analysis.

    Glass LC, Qu Y, Lenox S, Kim D, Gates JR, Brodows R, Trautmann M, Bergenstal RM.

    Curr Med Res Opin. 2008 Mar;24(3):639-44. Epub 2008 Jan 23.PMID: 18218179 [PubMed - indexed for MEDLINE]Related articles

    6.

    Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin.

    Bowker SL, Majumdar SR, Veugelers P, Johnson JA.

    Diabetes Care. 2006 Feb;29(2):254-8.PMID: 16443869 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Comparison of extended-release metformin in combination with a sulfonylurea (glyburide) to sulfonylurea monotherapy in adult patients with type 2 diabetes: a multicenter, double-blind, randomized, controlled, phase III study.

    Lewin A, Lipetz R, Wu J, Schwartz S.

    Clin Ther. 2007 May;29(5):844-55.PMID: 17697903 [PubMed - indexed for MEDLINE]Related articles

    8.

    Changes in treatment after the start of oral hypoglycaemic therapy in Type 2 diabetes: a population-based study.

    Donnan PT, Steinke DT, Newton RW, Morris AD; DARTS/MEMO Collaboration.

    Diabet Med. 2002 Jul;19(7):606-10.PMID: 12099966 [PubMed - indexed for MEDLINE]Related articles

    9.

    Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: an interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trials.

    Buse JB, Klonoff DC, Nielsen LL, Guan X, Bowlus CL, Holcombe JH, Maggs DG, Wintle ME.

    Clin Ther. 2007 Jan;29(1):139-53.PMID: 17379054 [PubMed - indexed for MEDLINE]Related articles

    10.

    Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin.

    Evans JM, Ogston SA, Emslie-Smith A, Morris AD.

    Diabetologia. 2006 May;49(5):930-6. Epub 2006 Mar 9.PMID: 16525843 [PubMed - indexed for MEDLINE]Related articles

    11.

    Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients.

    Rosenstock J, Sugimoto D, Strange P, Stewart JA, Soltes-Rak E, Dailey G.

    Diabetes Care. 2006 Mar;29(3):554-9.PMID: 16505505 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents.

    Klein DJ, Cottingham EM, Sorter M, Barton BA, Morrison JA.

    Am J Psychiatry. 2006 Dec;163(12):2072-9.PMID: 17151157 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Long-term efficacy of metformin therapy in nonobese individuals with type 2 diabetes.

    Ong CR, Molyneaux LM, Constantino MI, Twigg SM, Yue DK.

    Diabetes Care. 2006 Nov;29(11):2361-4.PMID: 17065668 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Glimepiride versus metformin as monotherapy in pediatric patients with type 2 diabetes: a randomized, single-blind comparative study.

    Gottschalk M, Danne T, Vlajnic A, Cara JF.

    Diabetes Care. 2007 Apr;30(4):790-4.PMID: 17392540 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Weight changes following the initiation of new anti-hyperglycaemic therapies.

    Nichols GA, Gomez-Caminero A.

    Diabetes Obes Metab. 2007 Jan;9(1):96-102.PMID: 17199724 [PubMed - indexed for MEDLINE]Related articles

    16.

    Weight gain in type 2 diabetes mellitus--not all uphill.

    Cohen O, Norymberg C, Neumann E, Dekel H.

    Diabetes Res Clin Pract. 2008 Jan;79(1):128-32. Epub 2007 Aug 27.PMID: 17720273 [PubMed - indexed for MEDLINE]Related articles

    17.

    Loss of glycemic control in patients with type 2 diabetes mellitus who were receiving initial metformin, sulfonylurea, or thiazolidinedione monotherapy.

    Riedel AA, Heien H, Wogen J, Plauschinat CA.

    Pharmacotherapy. 2007 Aug;27(8):1102-10.PMID: 17655510 [PubMed - indexed for MEDLINE]Related articles

    18.

    Thailand diabetes registry project: glycemic control in Thai type 2 diabetes and its relation to hypoglycemic agent usage.

    Kosachunhanun N, Benjasuratwong Y, Mongkolsomlit S, Rawdaree P, Plengvidhya N, Leelawatana R, Bunnag P, Pratipanawatr T, Krittiyawong S, Suwanwalaikorn S, Deerochanawong C, Chetthakul T, Ngarmukos C, Komoltri C.

    J Med Assoc Thai. 2006 Aug;89 Suppl 1:S66-71.PMID: 17715836 [PubMed - indexed for MEDLINE]Related articles

    19.

    2-year effects of pioglitazone add-on to sulfonylurea or metformin on oral glucose tolerance in patients with type 2 diabetes.

    Seufert J, Urquhart R.

    Diabetes Res Clin Pract. 2008 Mar;79(3):453-60. Epub 2007 Dec 26.PMID: 18160120 [PubMed - indexed for MEDLINE]Related articles

    20.

    An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with metformin as adjunctive therapy in patients with type 2 diabetes poorly controlled on a sulfonylurea.

    Barnett AH, Dreyer M, Lange P, Serdarevic-Pehar M.

    Diabetes Care. 2006 Jun;29(6):1282-7.PMID: 16732009 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity